The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence: A Randomized Clinical Trial
Open accessAbstract
IMPORTANCE: Opioid-dependent patients often use the emergency department (ED) for medical care. OBJECTIVE: To test the efficacy of 3 interventions for opioid dependence: (1) screening and referral to treatment (referral); (2) screening, brief intervention, and facilitated referral to community-based treatment services (brief intervention); and (3) screening, brief intervention, ED-initiated treatment with buprenorphine/naloxone, and referral to primary care for 10-week follow-up (buprenorphine). DESIGN, SETTING, AND PARTICIPANTS: A randomized clinical trial involving 329 opioid-dependent patients who were treated at an urban teaching hospital ED from April 7, 2009, through June 25, 2013. INTERVENTIONS: After screening, 104 patients were randomized to the referral group, 111 to the brief intervention group, and 114 to the buprenorphine treatment group. MAIN OUTCOMES AND MEASURES: Enrollment in and receiving addiction treatment 30 days after randomization was the primary outcome. Self-reported days of illicit opioid use, urine testing for illicit opioids, human immunodeficiency virus (HIV) risk, and use of addiction treatment services were the secondary outcomes. RESULTS: Seventy-eight percent of patients in the buprenorphine group (89 of 114 [95% CI, 70%-85%]) vs 37% in the referral group (38 of 102 [95% CI, 28%-47%]) and 45% in the brief intervention group (50 of 111 [95% CI, 36%-54%]) were engaged in addiction treatment on the 30th day after randomization (P < .001). The buprenorphine group reduced the number of days of illicit opioid use per week from 5.4 days (95% CI, 5.1-5.7) to 0.9 days (95% CI, 0.5-1.3) vs a reduction from 5.4 days (95% CI, 5.1-5.7) to 2.3 days (95% CI, 1.7-3.0) in the referral group and from 5.6 days (95% CI, 5.3-5.9) to 2.4 days (95% CI, 1.8-3.0) in the brief intervention group (P < .001 for both time and intervention effects; P = .02 for the interaction effect). The rates of urine samples that tested negative for opioids did not differ statistically across groups, with 53.8% (95% CI, 42%-65%) in the referral group, 42.9% (95% CI, 31%-55%) in the brief intervention group, and 57.6% (95% CI, 47%-68%) in the buprenorphine group (P = .17). There were no statistically significant differences in HIV risk across groups (P = .66). Eleven percent of patients in the buprenorphine group (95% CI, 6%-19%) used inpatient addiction treatment services, whereas 37% in the referral group (95% CI, 27%-48%) and 35% in the brief intervention group (95% CI, 25%-37%) used inpatient addiction treatment services (P < .001). CONCLUSIONS AND RELEVANCE: Among opioid-dependent patients, ED-initiated buprenorphine treatment vs brief intervention and referral significantly increased engagement in addiction treatment, reduced self-reported illicit opioid use, and decreased use of inpatient addiction treatment services but did not significantly decrease the rates of urine samples that tested positive for opioids or of HIV risk. These findings require replication in other centers before widespread adoption. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00913770.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Gueorguieva, R., & Krystal, J. H. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.310 · Cited by 1,529
The Clinical Opiate Withdrawal Scale (COWS)
Wesson, D. R., & Ling, W. (2003) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2003.10400007 · Cited by 1,120
Generation of allocation sequences in randomised trials: chance, not choice
Schulz, K. F., & Grimes, D. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07683-3 · Cited by 774
Madras, B. K., Compton, W. M., Avula, D., Stegbauer, T., Stein, J. B., & Clark, H. W. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.08.003 · Cited by 663
CDC grand rounds: prescription drug overdoses - a U.S. epidemic.
(2012) · PubMed · Cited by 494
Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence
Uchtenhagen, A. (2009) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-17408 · Cited by 490
A New Measure of Substance Abuse Treatment Initial Studies of the Treatment Services Review
McLELLAN, A. T., ALTERMAN, A. I., CACCIOLA, J., METZGER, D., & OʼBRIEN, C. P. (1992) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199202000-00007 · Cited by 421
Jonas, D. E., Garbutt, J. C., Amick, H. R., Brown, J. M., Brownley, K. A., Council, C. L., Viera, A. J., Wilkins, T. M., Schwartz, C. J., Richmond, E. M., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-9-201211060-00544 · Cited by 387
Brief motivational intervention at a clinic visit reduces cocaine and heroin use
Bernstein, J., Bernstein, E., Tassiopoulos, K., Heeren, T., Levenson, S., & Hingson, R. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.07.006 · Cited by 363
Counseling plus Buprenorphine–Naloxone Maintenance Therapy for Opioid Dependence
Fiellin, D. A., Pantalon, M. V., Chawarski, M. C., Moore, B. A., Sullivan, L. E., O'Connor, P. G., & Schottenfeld, R. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055255 · Cited by 351
Self-citationOral substitution treatment of injecting opioid users for prevention of HIV infection
Gowing, L., Farrell, M. F., Bornemann, R., Sullivan, L. E., & Ali, R. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004145.pub4 · Cited by 296
Screening and Brief Intervention for Drug Use in Primary Care: The ASPIRE Randomized Clinical Trial
Saitz, R., Palfai, T. P. A., Cheng, D. M., Alford, D. P., Bernstein, J. A., Lloyd-Travaglini, C. A., Meli, S. M., Chaisson, C. E., & Samet, J. H. (2014) · JAMA · doi:10.1001/jama.2014.7862 · Cited by 280
Darke, S., Hall, W., Heather, N., Ward, J., & Wodak, A. (1991) · AIDS · doi:10.1097/00002030-199102000-00008 · Cited by 270
(2010) · PsycEXTRA Dataset · doi:10.1037/e562742010-002 · Cited by 224
Humeniuk, R., Ali, R., Babor, T., Souza‐Formigoni, M. L. O., de Lacerda, R. B., Ling, W., McRee, B., Newcombe, D., Pal, H., Poznyak, V., et al. (2012) · Addiction · doi:10.1111/j.1360-0443.2011.03740.x · Cited by 211
A Brief Intervention Reduces Hazardous and Harmful Drinking in Emergency Department Patients
D'Onofrio, G., Fiellin, D. A., Pantalon, M. V., Chawarski, M. C., Owens, P. H., Degutis, L. C., Busch, S. H., Bernstein, S. L., & O'Connor, P. G. (2012) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2012.02.006 · Cited by 207
Bernstein, E., Edwards, E., Dorfman, D., Heeren, T., Bliss, C., & Bernstein, J. (2009) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2009.00490.x · Cited by 207
Cai, R., Crane, E., Poneleit, K., & Paulozzi, L. (2010) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.3109/15360288.2010.503730 · Cited by 197
Roy-Byrne, P., Bumgardner, K., Krupski, A., Dunn, C., Ries, R., Donovan, D., West, I. I., Maynard, C., Atkins, D. C., Graves, M. C., et al. (2014) · JAMA · doi:10.1001/jama.2014.7860 · Cited by 188
A Randomized Controlled Trial of Interim Methadone Maintenance
Schwartz, R. P., Highfield, D. A., Jaffe, J. H., Brady, J. V., Butler, C. B., Rouse, C. O., Callaman, J. M., O’Grady, K. E., & Battjes, R. J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.1.102 · Cited by 162
A Randomized Trial of Cognitive Behavioral Therapy in Primary Care-based Buprenorphine
Fiellin, D. A., Barry, D. T., Sullivan, L. E., Cutter, C. J., Moore, B. A., O'Connor, P. G., & Schottenfeld, R. S. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.07.005 · Cited by 159
Self-citationBarber, J., & Critis-Christoph, P. (1996) · Psychotherapy Research · doi:10.1080/10503309612331331608 · Cited by 133
Brief intervention for hazardous and harmful drinkers in the emergency department
D'Onofrio, G., Pantalon, M. V., Degutis, L. C., Fiellin, D. A., Busch, S. H., Chawarski, M. C., Owens, P. H., & O'Connor, P. G. (2008) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2007.11.028 · Cited by 129
Self-citationHome Buprenorphine/Naloxone Induction in Primary Care
Lee, J. D., Grossman, E., DiRocco, D., & Gourevitch, M. N. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0866-8 · Cited by 125
D’Onofrio, G., Pantalon, M. V., Degutis, L. C., Fiellin, D. A., & O’Connor, P. G. (2005) · Academic Emergency Medicine · doi:10.1197/j.aem.2004.10.021 · Cited by 121
Self-citationBogenschutz, M. P., Donovan, D. M., Mandler, R. N., Perl, H. I., Forcehimes, A. A., Crandall, C., Lindblad, R., Oden, N. L., Sharma, G., Metsch, L., et al. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.4052 · Cited by 118
D’Onofrio, G., & Degutis, L. C. (2010) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2010.00824.x · Cited by 114
Self-citationDavoli, M., Amato, L., Clark, N. C., Farrell, M., Hickman, M., Hill, S. R., Magrini, N., Poznyak, V. B., & Schünemann, H. J. (2014) · Addiction · doi:10.1111/add.12788 · Cited by 103
New Federal Initiatives To Enhance the Medical Treatment of Opioid Dependence
Fiellin, D. A., & O’Connor, P. G. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-8-200210150-00014 · Cited by 97
Self-citationA randomized trial of a brief alcohol intervention for needle exchangers (BRAINE)
Stein, M. D., Charuvastra, A., Maksad, J., & Anderson, B. J. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00102.x · Cited by 64
Narrative Review: Buprenorphine for Opioid-Dependent Patients in Office Practice
Sullivan, L. E., & Fiellin, D. A. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-9-200805060-00006 · Cited by 62
Self-citationKunins, H. V., Sohler, N., Giovanniello, A., Thompson, D., & Cunningham, C. O. (2012) · Substance Abuse · doi:10.1080/08897077.2012.752777 · Cited by 48
Gunderson, E. W., Wang, X.-Q., Fiellin, D. A., Bryan, B., & LEVIN, F. R. (2010) · Addictive Behaviors · doi:10.1016/j.addbeh.2010.01.001 · Cited by 47
Self-citationRabe, G. L., Wellmann, J., Bagos, P. G., Busch, M. A., Hense, H. W., Spies, C., Weiß-Gerlach, E., McCarthy, W. J., Arizaga, M. J. G., & Neuner, B. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts212 · Cited by 32
Pantalon, M. V., Martino, S., Dziura, J., Li, F.-Y., Owens, P. H., Fiellin, D. A., O'Connor, P. G., & D'Onofrio, G. (2012) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2012.08.011 · Cited by 30
Self-citationBernstein, S. L., Bijur, P. E., Cooperman, N. A., Jearld, S., Arnsten, J. H., Moadel, A. B., & Gallagher, E. J. (2012) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2012.05.005 · Cited by 24
Self-citation
Cited by
Larochelle, M. R., Bernson, D., Land, T., Stopka, T. J., Wang, N., Xuan, Z., Bagley, S. M., Liebschutz, J. M., & Walley, A. Y. (2018) · Annals of Internal Medicine · doi:10.7326/m17-3107 · Cited by 1,076
“Opioid prescription 7185 (41) 5039 (41) 598 (42) 917 (41) 265 (34) 366 (43)”
Treatment of opioid-use disorders
Schuckit, M. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1604339 · Cited by 540
The changing opioid crisis: development, challenges and opportunities
Volkow, N. D., & Blanco, C. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0661-4 · Cited by 522
A review: Fentanyl and non-pharmaceutical fentanyls
Suzuki, J., & El-Haddad, S. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.11.033 · Cited by 445
Management of opioid use disorders: a national clinical practice guideline
Bruneau, J., Ahamad, K., Goyer, M.-È., Poulin, G., Selby, P., Fischer, B., Wild, T. C., & Wood, E. (2018) · Canadian Medical Association Journal · doi:10.1503/cmaj.170958 · Cited by 412
Metadata
- Authors
- D’Onofrio, G., O’Connor, P. G., Pantalon, M. V., Chawarski, M. C., Busch, S. H., Owens, P. H., Bernstein, S. L., & Fiellin, D. A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2015-04-28
- Volume
- 313
- Issue
- 16
- Pages
- 1636
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2158292788
- Cited by
- 910
- References
- 38
- FWCI
- 48.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.